Latest news
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:21:30 GMTCogent’s Bezuclastinib Could Reach FDA Decisions in Nov., Dec. - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTJade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 11:19:42 GMTXenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform - Voice of AlexandriaVoice of Alexandria · Fri, 07 Aug 2026 12:37:09 GMTSolid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:08:00 GMTPulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results - Business WireBusiness Wire · Thu, 06 Aug 2026 20:05:00 GMTMBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:00:00 GMTAn MBX Biosciences obesity candidate showed 7% mean weight loss in 8 weeks - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT